To celebrate the release of COSMIC v99, we delve into how focusing on expert manual curation of specific genes, resistance mutations & more, emulates our dedication to being a reliable, sustainable source of genomic data on somatic mutations in cancer
As he prepared to step down as director of The Sanger Institute we interviewed Sir Professor Mike Stratton. Join us as we reflect on his fascinating career, his role in the early days of COSMIC and his advice for aspiring scientists!
To celebrate COSMIC v98’s release, we took inspiration from our curation team’s aim to improve representation of the plethora of rare subtypes of skin cancer and bring you three things you may not know about skin cancer!
Dr Maria Zhivagui discusses her research that’s captured the attention of the cancer research community and public alike. Explore the deleterious effects UV nail dryers can have on DNA, possible long term consequences of these damages and much more!
The COSMIC team is delighted to welcome our new director Jon Teague!
Join us and Dr Gianmarco Contino MD PhD, associate Professor of Cancer Genomic Medicine and an Honorary Upper Gastrointestinal Surgery Consultant as we explore his broad range of work from gene panels and tumour boards, to his clinical specialty: Oesophageal cancer.
We caught up with Dr. Guannan Wang to explore how her team’s first-of-its-kind canine precision oncology database could affect cancer research and patient outcomes for canines and humans alike.
Dr Carla Daniela Robles-Espinoza delves into her research on the genetic causes of acral lentiginous melanoma. Explore the role COSMIC played and how studies like this could help to close the care gap for lesser researched diseases.
With 1.24 million yearly occurrences, haematological cancers are the fifth most common type of cancer in the world. Here’s a sneak peak into three papers curated as part of our v97 update, each highlighting unique areas of research improving the outcomes for haematological cancer patients.
Copy Number Signatures are the latest addition to COSMIC Mutational Signatures, I caught up with one of the leads, Dr Ludmil Alexandrov, to discuss the key findings, utility of the data, and hopes for the future.